- Home
- SGA vs FORA Comparison
SGA vs FORA Comparison
Compare SGA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGA
- FORA
- Stock Information
- Founded
- SGA 1986
- FORA 2014
- Country
- SGA United States
- FORA United States
- Employees
- SGA N/A
- FORA N/A
- Industry
- SGA Broadcasting
- FORA Computer Software: Prepackaged Software
- Sector
- SGA Consumer Discretionary
- FORA Technology
- Exchange
- SGA Nasdaq
- FORA Nasdaq
- Market Cap
- SGA 78.8M
- FORA 69.4M
- IPO Year
- SGA 1992
- FORA N/A
- Fundamental
- Price
- SGA $12.00
- FORA $2.14
- Analyst Decision
- SGA
- FORA Strong Buy
- Analyst Count
- SGA 0
- FORA 1
- Target Price
- SGA N/A
- FORA $5.00
- AVG Volume (30 Days)
- SGA 6.6K
- FORA 39.2K
- Earning Date
- SGA 11-06-2025
- FORA 11-11-2025
- Dividend Yield
- SGA 8.33%
- FORA N/A
- EPS Growth
- SGA N/A
- FORA N/A
- EPS
- SGA 0.03
- FORA N/A
- Revenue
- SGA $109,822,000.00
- FORA $25,031,040.00
- Revenue This Year
- SGA N/A
- FORA $47.82
- Revenue Next Year
- SGA $5.37
- FORA $10.11
- P/E Ratio
- SGA $431.73
- FORA N/A
- Revenue Growth
- SGA N/A
- FORA 18.59
- 52 Week Low
- SGA $10.75
- FORA $1.64
- 52 Week High
- SGA $14.27
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- SGA 47.46
- FORA 48.67
- Support Level
- SGA $11.68
- FORA $2.14
- Resistance Level
- SGA $12.30
- FORA $2.22
- Average True Range (ATR)
- SGA 0.30
- FORA 0.11
- MACD
- SGA -0.01
- FORA -0.01
- Stochastic Oscillator
- SGA 51.51
- FORA 25.81
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.